Clinical Trial

Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive

SALT LAKE CITY, June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and…

3 days ago

Tigermed Advances Clinical Data Management with Veeva Vault EDC

Modern EDC streamlines key processes to accelerate study builds and make mid-study amendments with no downtime PLEASANTON, Calif., June 6,…

3 days ago

How Merck Scientists Are Driving Next-Generation Cancer Research

The company's scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit…

3 days ago

FDA Accepts for Review Treosulfan NDA Resubmission

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 6, 2024) - On Thursday, June 6, 2024, Medexus Pharmaceuticals (TSX: MDP)…

3 days ago

Moderna’s Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program

Center for Biologics Evaluation and Research has chosen mRNA-3705 as one of four investigational medicines for accelerated development to address…

3 days ago

Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference

New research data confirms superiority of TRUFORMA's Bulk Acoustic Wave Sensor technology in diagnosing feline hyperthyroidism ANN ARBOR, MI /…

3 days ago

Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer   

Josep Catllà EVP, Chief Corporate Affairs Officer PARIS, FRANCE, 06 June 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global…

3 days ago

Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System

LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing…

3 days ago

SeaStar Medical Announces 25-for-1 Reverse Stock Split

DENVER, June 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions…

3 days ago

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on…

3 days ago